All Entries in the "Blood Cancer" Category
Novel PCI-32765 Cancer Therapy Offers Optimism to Leukemia, Lymphoma Sufferers
Cancer investigators are hopeful about a new-fangled treatment for those patients inflicted with particular forms of leukemia and lymphoma.
An assessment of the new-fangled medicine, PCI-32765 in its first phase clinical study is one of the thirty-five ongoing clinical trials via a joint venture between TGen’s Clinical Division (Translational Genomics Research Institute) and Virginia G. Piper Cancer Center. This alliance facilitates genomics and molecular inventions to become obtainable to patients via the first phase of the clinical trials as soon as doable.
Several experts have pointed out to the excruciatingly sluggish advancement in the development of novel cancer treatments solely due to merely two to four percent of all cancer sufferers enrolling in clinical studies. This is largely [...]
Mar 02, 2010 | Comments 0
Headway in Leukemia Vaccine Development Shows Potential
Investigators from Britain have come up with a cure that could be employed for halting the disease relapsing following chemotherapy or BMT (bone marrow transplant).
In the long run, it is anticipated that the drug that could activate the body’s own immune system to combat leukemia, may well be utilized for treating other cancer forms.
The entrants in the study had acute myeloid leukemia or AML, the widespread type found in adults. Despite undergoing belligerent treatment, nearly half of them would generally experience the disease to recur.
The thought behind cancer vaccine is not essentially preventing the disease but rather programming the body’s immune system in hunting down cancerous cells and obliterating them. The vaccine then elicits the immune system in recognising leukemia [...]
Feb 19, 2010 | Comments 0
Crucial Gene Identification Would Aid In Adeptly Steering Acute Lymphoblastic Leukemia Treatment
Oncologists have detected explicit genes named partner genes which combine with another type of gene for driving a pre-dominantly terminal kind of leukemia among children. Researchers anticipate that by more accurate identification of particular partner genes would aid in better forecasting which children could gain from specific treatments.
Oncologists additionally intend to employ this recent know-how for developing novel and more effectual treatments for acute lymphoblastic leukemia, the most stubborn of all the types of leukemia. The oncologists are aiming at targeting treatments to particular genes and other related factors that turn anomalous due to gene fusions.
ALL is the widespread form of all the childhood cancers. Even though there has been a surge of survival rates in kids [...]
Dec 14, 2009 | Comments 0
Novel Use Of Umbilical Cord Blood For Reducing Risk Of Leukemia Relapse
A novel leukemia research conducted in the Masonic Cancer Center, University of Minnesota reveals that those patients having acute leukemia when administered transplantation of 2 units of UCB or umbilical cord blood had extensive reduction in risk of the disease relapsing. This discovery shows promise in changing the present medical practice of employing a single UCB unit for treating patients having a high risk of relapse of leukemia and other kinds of cancers affecting the blood and bone marrow.
Michael Verneris, M.D., and John Wagner, M.D., who have dedicated themselves to the research and treatment of infants having cancer, helmed the research team on this innovative study. The outcomes of this study are printed in the present edition of the medical journal ‘Blood’. This study was [...]
Nov 24, 2009 | Comments 0
Hairy Cell Leukemia Treatment
Treatment and Drugs
Treatment is not always required for individuals having hairy cell leukemia as this type of cancer has a slow progression rate and at times does not advance at all, some individuals would rather follow the wait and watch policy and prefer getting treated solely after they start becoming symptomatic. The major populace of individuals having hairy cell leukemia would ultimately require treatment.
Though one might be keen to free one’s body of any malignancy following diagnosis with hairy cell leukemia, there are no benefits of early treatment. In contrast to few other forms of cancer, hairy cell leukemia is relatively curable in all stages, translating to the fact that remission would not be any lesser if one adopted the wait and watch approach for treatment.
In case [...]
Nov 12, 2009 | Comments 0
Hairy Cell Leukemia : Detection And Likely Complications
Diagnosis & Tests:
In case there are doubts about the presence of hairy cell leukemia then the doctor would be observant for the following three signs:
Spleen enlargement.
Lower count of all the types of blood cells.
Presence of hairy cell leukemia in the blood.
In order to look out for these indicators the doctor would carry out several tests and examinations that would comprise of:
Physical Examination
The doctor would palpate the ellipsoidal-shaped organ placed to the left side of the upper part of the abdomen to check whether there is any kind of enlargement. An enlargement in the spleen could lead to feeling full in the abdomen that could cause discomfort during eating. The doctor might additionally look out for any enlargement in the lymph nodes that could point to [...]
Nov 12, 2009 | Comments 0
Hairy Cell Leukemia
Hairy cell leukemia is an atypical, gradually progressing cancer of the blood wherein there is excessive production of the B cells or lymphocytes (kind of infection-combatant white blood cells) in the bone marrow. These surfeit B cells are anomalous and appear ‘hairy’ microscopically due to the fine protuberances or villi from their surface. Due to the surge in amounts of leukemia cells, there is lesser production of healthy white blood cells, red blood cells and platelets.
Annually in the United States, nearly 600-800 individuals are detected with hairy cell leukemia. Hairy cell leukemia is observed to affect the male gender greater than the female, occurring mostly in the middle-age bracket or elderly individuals. Hairy cell leukemia is not known to affect kids and those in their teens.
Doctors [...]
Nov 11, 2009 | Comments 0
Hairy Cell Leukemia Treatment With Cladribine- Probable Side Effects
Cladribine (Cladribine Novaplus, Leustatin)
Cladribine is a cancer or antineoplastic medication for treating a form of blood cancer (Hairy Cell Leukemia) that hinders the spread of cancer cells, retarding their growth and proliferation in the body. Cladribine, however, has been additionally employed for other purposes.
Likely Side effects of cladribine (Cladribine Novaplus, Leustatin)
In case one is experiencing any of the below stated grave side effects, then it is vital to seek prompt medical assistance or get in touch with one’s doctor urgently.
An allergic reaction characterised by shortened breath; feeling a restricted or closed sensation in the throat; breathing distress; the lips, face or tongue swelling up or appearance of hives.
Lowered functioning of the bone marrow and [...]
Nov 10, 2009 | Comments 0
Infant Leukemia – 8 Prevalent Signs No Parent Must Ignore
Leukemia cancer is the cancer of the cells leading to irregularity of the blood cells that could have a damaging effect on the chromosomes or genes. Leukemia is the widespread reason for cancer fatalities among infants known to affect more often the white populace than the dark skin tones.
There are varied kinds of leukemia from which 2 namely; acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML) are widely observed to affect children.
8 Caveat Signs Of Child Leukemia
Susceptibility to Infection
Child leukemia could lead to high fever and severe infirmity, however it is immune to antibiotics. It is primarily due to the dearth of white blood cells, particularly mature granulocytes. Though it leads to the elevated production of white blood cells, these cells prove [...]
Nov 09, 2009 | Comments 0
Acute Myeloid Leukemia (AML)
Diagnosis & Tests
The doctor would initially conduct a thorough physical exam and check whether the liver, spleen, groin, neck and lymph nodes in the under arms are showing any kind of swelling.
A CBC blood test would be ordered for finding out the complete blood count that evaluates the number of white and red blood cells and platelet count in the blood. Additionally, the blood sample is microscopically analysed to check for appearance of the cells and in determining the amount of mature cells and leukemia cells known as blasts. Though blood tests might show the presence but they mostly do not reveal the type of leukemia that is present.
For further identification of the type of leukemia, a bone marrow aspiration and biopsy procedure is conducted by the haematologist (specialist [...]
Nov 04, 2009 | Comments 0







